IL6 and COVID-19: A strength of this research is that it provides scientific evidence indicating that comorbidities such as obesity, T2DM, and hypertension, as well as elevated levels of glucose, IL-6, LDH and CRP are associated with the COVID-19 severity among ICU-admitted patients.